10-Mar-2010
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
About
|
Faculty Member List
|
Associate FMs
|
F1000 Reports
Search
All F1000
Hematology
Top 10s
Hematology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Anemias & Hypocellular Marrow Disorders
Bleeding & Coagulation Disorders
Hematologic Transplantation & Transfusion
Hematopoietic Stem Cells
Leukemia & Proliferative Disorders of Hematic Cells
Lymphomas & Myelomas
Non-hematopoietic Stem Cells
Pediatric Hematology
Related Sections
Perioperative Hemostasis & Transfusion Medicine
HIDDEN JEWELS | Hematology | calculated on 9 March 2010
The "Hidden Jewels" Top 10 lists are generated every day and comprise only articles published in less widely distributed journals. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days. The general journals and specialty journals excluded from this list are:
Ama Arch Intern Med, Ann Intern Med, Blood, BMJ, Cell, CMAJ, J Clin Invest, JAMA, Lancet, N Engl J Med, Nat Med, Nature, Science.
browse faculty
| show Hidden Jewels in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
New Finding
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
Taylor CM, Machin S, …, Goodship TH, working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society
Br J Haematol
2010 Jan
148
(1):37-47 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Paula Bolton-Maggs
Evaluated 9 Feb 2010
2
Recommended
F1000 Factor
3.0
New Finding
Tech Advance
Expensive blood safety initiatives may offer less benefit than we think.
Kamper-Jørgensen M, Hjalgrim H, …, Nyrén O, Rostgaard K
Transfusion
2009 Sep 16 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Eberhard Fiebig
Evaluated 11 Feb 2010
3
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.
van Rood JJ, Stevens CE, …, Carpenter C, Scaradavou A
Proc Natl Acad Sci U S A
2009 Nov 24
106
(47):19952-7 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Effie Petersdorf
Evaluated 10 Feb 2010
4
Must Read
F1000 Factor
4.8
New Finding
Tech Advance
Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential.
Benveniste P, Frelin C, …, Hyam D, Iscove NN
Cell Stem Cell
2010 Jan 8
6
(1):48-58 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Christoph Schaniel and Kateri Moore / David L Stachura and David Traver
First evaluation 24 Feb 2010 | Latest evaluation 25 Feb 2010
5
Recommended
F1000 Factor
3.0
New Finding
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Finke J, Bethge WA, …, Socié G, ATG-Fresenius Trial Group
Lancet Oncol
2009 Sep
10
(9):855-64 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Didier Blaise
Evaluated 23 Nov 2009
6
Recommended
F1000 Factor
3.0
New Finding
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.
Ruella M, Rocci A, …, Corradini P, Tarella C
Bone Marrow Transplant
2009 Oct 19 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Shahinaz Gadalla and Sharon Savage
Evaluated 26 Feb 2010
7
Recommended
F1000 Factor
3.0
New Finding
Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals.
Derudder E, Cadera EJ, …, Schmidt-Supprian M, Rajewsky K
Nat Immunol
2009 Jun
10
(6):647-54 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stephen A Mihalcik and Diane Jelinek
Evaluated 10 Jul 2009
8
Recommended
F1000 Factor
3.0
New Finding
Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells.
Langenkamp U, Siegler U, …, Kalberer CP, Wodnar-Filipowicz A
Haematologica
2009 Nov
94
(11):1590-4 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Brent A Williams and Armand Keating
Evaluated 2 Feb 2010
9
Recommended
F1000 Factor
3.0
New Finding
Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B, Schonewille H, Ndugwa C, Brand A
Transfusion
2009 Oct 10
50
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Julie Karp and Beth Shaz
Evaluated 17 Feb 2010
10
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U, Lia M, …, Bhagat G, Dalla-Favera R
Cancer Cell
2010 Jan 19
17
(1):28-40 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Renee C Tschumper and Diane Jelinek
Evaluated 26 Feb 2010
© 2010 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info
New Finding
Tech Advance
Hypothesis